Health Outcomes for Clients of Needle and
Syringe Programs in Prisons.
Lazarus JV, Safreed-Ha
rmon K, Hetherington KL,
et al
Epidemiol Rev.
2018 Apr 12
Abstract
Prescribing Opioid Replacement Therapy in
U.S. Correctional Settings.
Farahmand P, Modesto-Lowe V, Chaplin MM.
J Am Acad Psychiatry Law.
2017 Dec;45(4):472-477
Abstract
FULL-TEXT
ARTICLE
Cohort profile: seek, test, treat and retain United
States criminal justice cohort.
Chandler R, Gordon MS, Kruszka B, \ et al
Subst Abuse Treat Prev Policy.
2017 May 16;12(1):24
Paper
"It Goes on Everywhere": Injection Drug Use
in Canadian Federal Prisons.
van der Meulen E.
Subst Use Misuse. 2017 Jun
7;52(7):884-891.
Abstract
Childhood Adversities and Substance Misuse
Among the Incarcerated: Implications for Treatment and Practice in
Correctional Settings.
Marotta PL.
Subst Use Misuse. 2017 May
12;52(6):717-733.
Abstract
Addressing excess risk of overdose among
recently incarcerated people in the USA: harm reduction interventions in
correctional settings.
Brinkley-Rubinstein L, Cloud DH, et al
Int J Prison Health. 2017 Mar
13;13(1):25-31.
Abstract
Does exposure to opioid substitution
treatment in prison reduce the risk of death after release? A national
prospective observational study in England.
Marsden J, Stillwell G, Jones H,
et al
Addiction. 2017 Feb 4.
Abstract
Monitoring a Prison Opioid Treatment Program
Over a Period of Change to Clinical Governance Arrangements, 2007-2013.
Larney S, Lai W, Dolan K, Zador D.
J Subst Abuse Treat.
2016 Nov;70:58-63
Abstract
Resumption of injecting drug use following
release from prison in Australia.
Winter RJ, Young JT, Stoové M,
et al
Drug Alcohol Depend. 2016 Nov
1;168:104-111
Abstract
Decrease in self-reported offences and
incarceration rates during methadone treatment: A comparison between
patients switching from buprenorphine to methadone and maintenance treatment
incident users (ANRS-Methaville trial).
Carrieri P, Vilotitch A, Nordmann S,
et al
Int J Drug Policy. 2016 Oct
19;39:86-91
Abstract
FULL-TEXT ARTICLE
The
Prison Economy
of Needles and Syringes: What Opportunities Exist for Blood Borne Virus Risk
Reduction When Prices Are so High?
Treloar C, McCredie L, Lloyd AR.
PLoS One. 2016 Sep 9;11(9):e0162399.
Paper
Examining Treatment Climate Across
Prison-Based Substance Abuse Treatment Groups.
Kelly CE, Welsh WN.
Subst Use Misuse.
2016 Jun 6;51(7):902-11.
Abstract
Extended-release naltrexone opioid treatment
at jail re-entry (XOR).
McDonald RD, Tofighi B, Laska E, et al
Contemp Clin Trials. 2016 May 10.
Abstract
Factors associated with interest in receiving
prison-based methadone maintenance therapy in Malaysia.
Mukherjee TI, Wickersham JA,
et al
Drug Alcohol Depend. 2016
May 9
Abstract
Efficacy of a Computerized Intervention on HIV and
Intimate Partner Violence Among Substance-Using Women in Community
Corrections: A Randomized Controlled Trial.
Gilbert L, Goddard-Eckrich D, Hunt T, et al
Am J Public
Health. 2016 Apr 14:e1-e9
Abstract
Injecting drug use, sexual risk, HIV
knowledge and harm reduction uptake in a large prison in Bali, Indonesia.
Sawitri AA, Hartawan AA, Craine N,
et al
Int J Prison Health.
2016 Mar 14;12(1):27-38
Abstract
Prevalence and Correlates of the Use of
Prefilled Syringes Among Persons Who Inject Drugs in San Diego, CA.
Armenta RF, Roth AM, Wagner KD, et al
J Urban Health. 2015 Sep 17
Abstract
A cost-effectiveness analysis of opioid
substitution therapy upon release in reducing mortality among prisoners with
a history of opioid dependence.
Gisev N, Shanahan M, Weatherburn DJ,
Addiction. 2015 Jul 25.
Abstract
FULL-TEXT
ARTICLE
Therapeutic Community Treatment of an Inmate
Population with Substance Use Disorders: Post-Release Trends in Re-Arrest,
Re-Incarceration, and Drug Misuse Relapse.
Galassi A, Mpofu E, Athanasou J.
Int J Environ Res Public Health.
2015 Jun 19;
Paper
Methadone continuation versus forced
withdrawal on incarceration in a combined US prison and jail: a
randomised, open-label trial.
Rich JD, McKenzie M, Larney S, et al
Lancet.
2015 May 28
Abstract
Substance Use and HIV Among Female Sex
Workers and Female Prisoners: Risk Environments and Implications for
Prevention, Treatment, and Policies.
Strathdee SA, West BS, Reed E, et al
J Acquir Immune Defic Syndr. 2015
Jun 1;69 Suppl 1:S110-S117.
Abstract
People who inject drugs in prison: HIV
prevalence, transmission and prevention.
Dolan K, Moazen B, Noori A, et al
I
nt J Drug Policy. 2015 Feb;26 Suppl
1:S12-5.
Abstract
Prison outcomes of buprenorphine maintenance
for prisoners: results from a pilot intervention in Tihar prisons, India.
Jhanjee S, Pant S, Girdhar N, et al
Alcohol Alcohol. 2014
Sep;49 Suppl 1:i64-i65
Abstract
FULL-TEXT ARTICLE
Selection of Variables that Influence Drug Injection
in Prison: Comparison of Methods with Multiple Imputed Data Sets.
Haji-Maghsoudi S, Haghdoost AA, Baneshi MR.
Addict Health. 2014 Winter;6(1-2):36-44.
Paper
Medication-assisted treatment for opioid use
disorders in correctional settings: An ethics review.
Ludwig AS, Peters RH.
Int J Drug Policy. 2014
Aug 30.
Abstract
FULL-TEXT
PDf ARTICLE
Incidence and correlates of hepatitis C virus
infection in a large cohort of prisoners who have injected drugs
Snow KJ, Young JT, Preen DB, et al
BMC Public Health. 2014
Aug 11;14(1):830.
Paper
Striking subgroup differences in
substance-related mortality after release from prison.
Forsyth SJ, Alati R, Ober C,
3t al
Addiction. 2014 Jun 10.
Abstract
A randomized controlled trial of
prison-initiated buprenorphine: Prison outcomes and community treatment
entry.
Gordon MS, Kinlock TW, Schwartz RP,
et al
Drug Alcohol Depend. 2014 Jun 2.
Abstract
An evaluation of hepatic enzyme elevations
among HIV-infected released prisoners enrolled in two randomized
placebo-controlled trials of extended release naltrexone.
Vagenas P, Di Paola A, Herme M, et al
J Subst Abuse Treat. 2014 Mar 12.
Abstract
FULL TEXT ARTICLE
Influence
of pattern of missing data on performance of imputation methods: an example
using national data on drug injection in prisons.
Haji-Maghsoudi S, Haghdoost AA, Rastegari A, Baneshi MR.
Int J Health Policy Manag.
2013 Jun 3;1(1):69-
Paper
Factors Influencing Drug Injection History among
Prisoners: A Comparison between Classification and Regression Trees and Logistic
Regression Analysis.
Rastegari A, Haghdoost AA, Baneshi MR.
Addict Health. 2013 Winter;5(1-2):7-15.
Abstract
Design and methods of a double blind randomized
placebo-controlled trial of extended-release naltrexone for alcohol dependent
and hazardous drinking prisoners with HIV who are transitioning to the
community.
Springer SA, Altice FL, Herme M, Di Paola A
.ontemp
Clin Trials. 2013 Dec 30
Abstract
Cost-effectiveness of HCV case-finding for
people who inject drugs via dried blood spot testing in specialist addiction
services and prisons.
Martin NK, Hickman M, Miners A, et al
BMJ Open. 2013 Aug 13;3(8).
Abstract
Cocaine Use Disorder Prevalence: From Current
DSM-IV to Proposed DSM-5 Diagnostic Criteria With Both a Two and Three Severity
Level Classification System.
Proctor SL, Kopak AM, Hoffmann NG.
Psychol Addict Behav.
2013 Aug 5
Abstract
Non-fatal overdose among adult prisoners with a
history of injecting drug use in two Australian states.
Moore E, Winter R, Indig D, et al
Drug Alcohol Depend.
2013 Jul 15.
Abstract
Bupropion diversion and misuse in the
correctional facility.
Hilliard WT, Barloon L, Farley P, et al
J Correct Health Care. 2013
Jul;19(3):211-7.
Abstract
Predictors of retention in a drug-free
unit/substance abuse treatment in prison.
Casares-López MJ,
González-Menéndez A, Festinger DS, et al
Int J Law Psychiatry. 2013
May-Aug;36(3-4):264-72.
Abstract
FULL-TEXT PDF ARTICLE
Body packing by rectal insertion of
cocaine packets: a case report.
Neves FF, Cupo P, Muglia VF,
et al
BMC Res Notes.
2013 May 3;6(1):178
Paper |
|
Take-Home Emergency Naloxone to Prevent
Heroin Overdose Deaths after Prison Release: Rationale and
Practicalities for
the N-ALIVE Randomized Trial.
Strang J, Bird SM, Parmar MK.
J Urban Healt
2013 May
Abstract
All-cause mortality in criminal justice
clients with substance use problems-A prospective follow-up study.
Hakansson A, Berglund M
Drug Alcohol Depend.
2013 Apr 24.
Abstract
Alcohol Use Disorder Diagnoses in
the Criminal Justice System: An Analysis of the Compatibility of
Current DSM-IV, Proposed DSM-5.0, and DSM-5.1 Diagnostic Criteria
in a Correctional Sample.
Kopak AM, Metze AV, Hoffmann NG
Int J Offender Ther Comp Criminol. 2013 Apr 17
Abstract
Disparities in Criminal Court
Referrals to Drug Treatment and Prison for Minority Men.
Nicosia
N, Macdonald JM, Arkes J.
Am J Public Health.
2013 Apr 18.
Abstract
Opiate substitution treatment to reduce
in-prison drug injection: A natural experiment.
Kinner SA, Moore E,
Spittal MJ, Indig D.
Int J Drug Policy.
2013 Mar 1.
Abstract
FULL-TEXT ARTICLE
Substance use among inmates at the Eldoret prison in Western Kenya.
Kinyanjui DW, Atwoli L.
BMC Psychiatry. 2013 Feb
13;13(1):53
Paper |
Methadone dose at the time of release from
prison significantly influences retention in treatment: Implications from a
pilot study of HIV-infected prisoners transitioning to the community in
Malaysia.
Wickersham JA, Zahari
MM, Azar MM, et al
Drug
Alcohol Depend. 2013 Feb 12.
Abstract
FULL-TEXT
ARTICLE
Overview of substance use disorders and incarceration of
African American males.
Mukku VK, Benson TG, Alam F, et al
Front Psychiatry. 2012;3:98.
Paper
Integrated services plus drug treatment as a system
alternative to crime control and parole.
Danzer G.
Soc Work Public Health.
2012 Nov;27(7):687-98.
Abstract
What predicts retention on an in-prison drug treatment
program?
Casares-López MJ, González-Menéndez A, Fernández P,
et al
Span J Psychol. 2012
Nov;15(3):1349-60.
Abstract |
FULL-TEXT
ARTICLE
Return to drug use and overdose after release from prison:
a qualitative study of risk and protective factors.
Binswanger IA, Nowels C, Corsi KF,
et al
Addict Sci Clin Pract.
2012;7(1):3.
Paper
FULL-TEXT
PDF ARTICLE
Risk
factors for criminal recidivism -- a prospective follow-up study in prisoners
with substance abuse.
Hakansson A, Berglund M.
BMC Psychiatry. 2012 Aug 15;12(1):111.
Paper |
Postprison Release HIV-Risk Behaviors in a
Randomized Trial of Methadone Treatment for Prisoners.
Wilson ME, Kinlock TW, Gordon MS,
et al
Am J Addict. 2012
Sep;21(5):476-87.
Abstract
Asociality and Engagement in Adult Offenders in
Substance Abuse Treatment.
Pankow J, Knight K.
Behav Sci Law. 2012 Jul 12.
Abstract
Predictors of Drug Use in Prison among
Incarcerated Black Men.
Rowell TL, Wu E, Hart CL, Haile R,
El-Bassel N.
Am J Drug Alcohol Abuse.
2012 Jul 2.
Abstract
FULL-TEXT ARTICLE
Retention on Buprenorphine Is Associated with High Levels
of Maximal Viral Suppression among
HIV-Infected Opioid Dependent Released Prisoners.
Springer SA, Qiu J, Saber-Tehrani AS, Altice
FL.
PLoS One. 2012;7(5):e38335
Paper
Tuberculosis and HIV in people who
inject drugs: evidence for action for tuberculosis, HIV,
prison and harm reduction services.
Getahun H, Gunneberg C,
Sculier D, et al
Curr Opin HIV AIDS.
2012 Jul;7(4):345-53.
Abstract |
An Evaluation of a Short-Term Drug Treatment
for Jail Inmates.
Bahr SJ, Harris PE, Strobell JH, Taylor BM.
Int J Offender Ther Comp Criminol.
2012 May 28.
Abstract |
Fitness levels and physical activity among class
A drug users entering prison.
Fischer J, Butt C, Dawes H,
et al
Br
J Sports Med. 2012 Apr 20
Abstract
Opioid maintenance in European prisons: is the
treatment gap closing?
Hedrich D, Farrell M.
Addiction. 2012 Mar;107(3):461-3
Abstract |
Medication-Assisted Treatment in Criminal Justice
Agencies Affiliated with the Criminal Justice-Drug
Abuse Treatment Studies (CJ-DATS): Availability, Barriers, and Intentions.
Friedmann PD, Hoskinson R, Gordon M, et al
Subst Abus. 2012 Jan;33(1):9-18.
Abstract
|
Substance abuse and criminal thinking:
Testing the countervailing, mediation, and specificity
hypotheses.
Walters GD.
Law Hum Behav.
2012 Jan 16
Abstract |
FULL-TEXT ARTICLE
Motivation for treatment among women
offenders in prison-based treatment and longitudinal outcomes
among those who participate in community aftercare.
Grella CE, Rodriguez L.
J Psychoactive Drugs.
2011 Sep;Suppl 7:58-67.
Paper |
An Adverse Reaction to
Buprenorphine/Naloxone Induction in Prison: A Case Report.
Rich JD,
McKenzie M, Dickman S,
et
al;
Addict Disord Their Treat.
2011 Dec;10(4):199-200.
Abstract
FULL-TEXT ARTICLE
A multi-site, randomized study of strengths-based case
management with substance-abusing parolees.
Prendergast M, Frisman L, Sacks JY,
et al
J Exp Criminol.
2011 Sep;7(3):225-253.
Paper
Guideline, Education, and Peer Comparison to Reduce
Prescriptions of Benzodiazepines and Low-Dose
Quetiapine in Prison.
Reeves R.
J Correct Health Care. 2011 Sep 30.
Abstract
The effectiveness of opioid maintenance treatment in prison
settings: a systematic review.
Hedrich D, Alves P, Farrell M,
et al
Addiction.
2011 Sep 29
Abstract
Therapeutic substance abuse treatment for
incarcerated women.
Finfgeld-Connett D, Johnson ED.
Clin Nurs Res. 2011
Nov;20(4):462-81.
Abstract
Development and validation of a self-rating scale for
betel quid chewers based on a male-prisoner population in Taiwan:
The Betel Quid Dependence Scale.
Lee CY, Chang CS, Shieh TY, Chang YY.
Drug Alcohol Depend.
2011 Sep 26.
Abstract
The effectiveness of opioid maintenance treatment in prison
settings: a systematic review.
Hedrich D, Alves P, Farrell M,
et al
Addiction.
2011 Sep 29
Abstract
Incarceration Predicts Virologic Failure for
HIV-Infected Injection Drug Users Receiving Antiretroviral Therapy.
Westergaard RP, Kirk GD, Richesson DR, et al
Clin Infect Dis. 2011
Oct;53(7):725-31.
Paper5
Effect of prison-based opioid substitution treatment, and
post-release retention in treatment, on risk of re-incarceration.
Larney S, Toson B, Burns L, Dolan K.
Addiction. 2011 Aug 18.
Abstract
Results of a
pilot
randomized controlled trial of buprenorphine for opioid dependent women in the
criminal justice system.
Cropsey KL, Lane PS, Hale GJ,
et al
Drug Alcohol Depend.
2011 Jul 20.
Abstract
A Case-control Study of HIV Infection Among
Incarcerated Female Drug Users: Impact of Sharing Needles and Having Drug-using
Sexual Partners.
Peng EY, Yeh CY, Cheng SH,
et
al
J Formos Med Assoc. 2011 Jul;110(7):446-53.
Abstract
Benefits and costs of substance abuse treatment programs
for state prison inmates: results from a
lifetime simulation model.
Zarkin GA, Cowell AJ, Hicks KA,
et al
Health Econ. 2011 Apr 19
Abstract
Mortality among a cohort of drug users after their
release from prison:
an evaluation of the effectiveness of a harm reduction
program in Taiwan.
Huang YF, Kuo HS, Lew-Ting CY,
et al
Addiction. 2011 Mar 25
Abstract
|
Journal
Citations
Women
and Substance Use